Over 2000 Employees Fired Overnight as Trump Administration Restructures Health Agencies
On February 14, the Trump administration initiated a sweeping layoff affecting more than 2000 employees in key health agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). This drastic move came on the first day of Robert F. Kennedy Jr.'s tenure as Secretary of Health and Human Services (HHS).
The initial layoff list indicated that approximately 1500 NIH employees and 1269 CDC employees would be affected. However, recent updates suggest that the number of layoffs at NIH has been adjusted to 1165. Among those terminated are many grassroots researchers, recently hired scientists, and department heads. This mass firing has raised significant concerns about the continuity of ongoing clinical trials, as the dismissal of clinical researchers could halt numerous projects.
Additionally, the Advanced Research Projects Agency for Health (ARPA-H), established just three years ago, has also seen its first director and a majority of staff let go. The agency was designed to fund high-risk, high-reward research with an annual budget of $1.5 billion. The layoffs extend beyond HHS, with reports indicating that the Environmental Protection Agency (EPA) may face similar cuts, potentially impacting 20% of its scientific workforce.
This restructuring raises alarms about the future of public health initiatives in the U.S., especially in areas critical for pandemic response and disease prevention.
2026-08-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
-
One Ton of Fake Plastic Nearly Burned China’s Manufacturing Reputation—Wanhua Chemical Exposes the Underbelly of the Chemical Black Market
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Wanhua’s Counter-Cyclical Expansion: A Gamble or a Strategic Move for the Next Cycle?
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
Henkel’s €60 Million Adhesive Technologies Inspiration Center in Shanghai Goes into Operation, Aiming to Build an R&D Hub for Asia-Pacific
-
Marinela Makeup Partners with FasterCapital to Scale Its Vegan Beauty Line
-
Dow × Hisense’s Innovation Code: A Deep Game of Sustainability
-
Givaudan Introduces New Labdanum Absolute for Fragrance Creations
-
IFF to Establish Scent Creative Center in Mumbai
Recommend Reading
-
Evonik Launches Asia’s First Alkoxide Plant in Jurong Island
-
IMCD to Acquire Tillmanns
-
¥20 Million Investment Lands in Qingdao: China and Japan Join Hands to Build High-Active Zinc Oxide Production Base
-
Wanhua Resumes PO Production: How Much Can Polyether Producers Save on Costs?
-
Röhm Opens MMA Plant in Texas
-
Downstream Demand Insufficient, Cyclohexane Market Negotiation Focus Shifts Lower
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
Ethylene Glycol Prices Ease Slightly on August 28
-
In August, the urea market in China showed a weak downward trend
-
August Aniline Market Stabilizes After Fluctuations in China